Vanda Pharmaceuticals (VNDA) Return on Sales (2010 - 2026)

Vanda Pharmaceuticals (VNDA) has 17 years of Return on Sales data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (down 1.0% YoY), and the FY2025 full-year result was 0.01%, down 1.0% from the prior year.
• Return on Sales grew to 0.01% in Q1 2026, from 0.02% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2022 to a low of 0.02% in Q4 2025.
• A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales changed 0 bps in 2022 and slipped 2 bps in 2025, its largest moves.
• Tracing VNDA's Return on Sales over 5 years: stood at 0.0% in 2022, then sank by 150 bps to 0.0% in 2023, then plunged by 74 bps to 0.0% in 2024, then slumped by 2592 bps to 0.02% in 2025, then surged by 62 bps to 0.01% in 2026.
• Business Quant data shows VNDA's Return on Sales at 0.01% in Q1 2026, 0.02% in Q4 2025, and 0.0% in Q3 2025.